MDT Jun 2024 120.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:16AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Medtronic Full Year 2024 Earnings: EPS Misses Expectations
Medtronic ( NYSE:MDT ) Full Year 2024 Results Key Financial Results Revenue: US$32.4b (up 3.6% from FY 2023). Net...
- Zacks
Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial
Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.
- Benzinga
Medtronic's Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend
Medtronic Plc (NYSE:MDT) reported fourth-quarter 2024 sales of $8.59 billion, beating the consensus of $8.44 billion. Revenue increased 0.5%, as reported, and 5.4% organic. The company’s organic revenue results reflect broad-based growth across the company, with mid-single-digit or higher organic revenue growth in all four segments. The medical device maker reported adjusted EPS of $1.46, beating the consensus of $1.45. Related: Medtronic’s Latest Generation Of Transcatheter Aortic Valve Replace
© 2024 Yahoo. All rights reserved.